Post-earnings recap
Reported
Wed, Feb 22, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $2.98, exceeding expectations by 8.21%. However, the stock fell by 10.06% in reaction to the earnings report. The decline may reflect investor concerns or broader market conditions, as no revenue figures or management commentary were provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.98 | N/A | +8.21% |
No transcript is on record, and the analysis is based on numerical results only.